Literature DB >> 31029232

Breast Ductal Carcinoma in Situ: Precursor to Invasive Breast Cancer.

William B Coleman1.   

Abstract

This Editorial introduces this month's special Breast Ductal Carcinoma in Situ Theme Issue, a series of reviews intended to highlight the relationship of ductal carcinoma in situ as a precursor to breast cancer and emphasize the need for appropriate treatment in hopes of minimizing the progression to invasive disease.
Copyright © 2019 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31029232     DOI: 10.1016/j.ajpath.2019.03.002

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  3 in total

1.  Radiological Underestimation of Tumor Size as a Relevant Risk Factor for Positive Margin Rate in Breast-Conserving Therapy of Pure Ductal Carcinoma In Situ (DCIS).

Authors:  Gesche Schultek; Bernd Gerber; Toralf Reimer; Johannes Stubert; Steffi Hartmann; Annett Martin; Angrit Stachs
Journal:  Cancers (Basel)       Date:  2022-05-11       Impact factor: 6.575

Review 2.  Influence of Fibroblasts on Mammary Gland Development, Breast Cancer Microenvironment Remodeling, and Cancer Cell Dissemination.

Authors:  Angelica Avagliano; Giuseppe Fiume; Maria Rosaria Ruocco; Nunzia Martucci; Eleonora Vecchio; Luigi Insabato; Daniela Russo; Antonello Accurso; Stefania Masone; Stefania Montagnani; Alessandro Arcucci
Journal:  Cancers (Basel)       Date:  2020-06-26       Impact factor: 6.639

3.  Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort study.

Authors:  Thomas E Rohan; Mindy Ginsberg; Yihong Wang; Fergus J Couch; Heather S Feigelson; Robert T Greenlee; Stacey Honda; Azadeh Stark; Dhananjay Chitale; Tao Wang; Xiaonan Xue; Maja H Oktay; Joseph A Sparano; Olivier Loudig
Journal:  BMJ Open       Date:  2021-10-26       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.